Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-4,790
Closed -$429K 602
2017
Q2
$429K Sell
4,790
-6,121
-56% -$517K 0.06% 437
2017
Q1
$879K Sell
10,911
-6,108
-36% -$477K 0.17% 227
2016
Q4
$1.29M Buy
17,019
+1,612
+10% +$124K 0.31% 94
2016
Q3
$1.25M Sell
15,407
-482
-3% -$36.5K 0.26% 116
2016
Q2
$1.04M Sell
15,889
-6,599
-29% -$442K 0.25% 133
2016
Q1
$1.46M Buy
22,488
+6,465
+40% +$409K 0.39% 45
2015
Q4
$1.1M Sell
16,023
-12,541
-44% -$857K 0.31% 81
2015
Q3
$1.99M Sell
28,564
-42,508
-60% -$3.18M 0.46% 13
2015
Q2
$5.16M Buy
71,072
+9,887
+16% +$678K 0.65% 26
2015
Q1
$4.1M Buy
61,185
+18,066
+42% +$1.14M 0.56% 29
2014
Q4
$2.54M Buy
+43,119
New +$2.46M 0.52% 47

Other funds holding IQV

GAM Systematic's IQV Position: Q3 2017 in Review

GAM Systematic sold out of IQVIA (IQV) in Q3 2017, closing a stake of 4,790 shares — an estimated $429K sold.

GAM Systematic first reported a position in IQV in Q4 2014 and held it in 11 quarters. The position peaked at $5.16M in Q2 2015. 472 funds tracked by Wall St. Rank hold IQV as of Q3 2017.

  • GAM Systematic reported no remaining IQVIA position as of Q3 2017 after selling out during the quarter.
  • GAM Systematic sold 4,790 IQVIA shares in Q3 2017, an estimated $429K.
  • GAM Systematic first reported a position in IQVIA in Q4 2014 and held it in 11 quarters.
  • GAM Systematic's IQVIA position peaked at $5.16M in Q2 2015.
  • 472 funds tracked by Wall St. Rank held IQVIA as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.